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Abstract
Introduction: Toxic epidermal necrolysis lies within the spectrum of severe cutaneous adverse reactions induced
by drugs, affecting skin and mucous membranes. Toxic epidermal necrolysis is considered a medical emergency as
it is considered to be potentially fatal and carries a high mortality rate. To the best of our knowledge the
association of toxic epidermal necrolysis and compartment syndrome has been rarely mentioned in the literature.
In this case we treated the compartment syndrome promptly despite the poor general condition and skin status of
our patient. Despite the poor skin condition, wound healing was uneventful with no complications.
Case presentation: A 62-year-old Caucasian man with a generalized macular-vesicular rash involving 90% of his
body surface area and mucous membranes, as well as impaired renal and hepatic functions following ingestion of
allopurinol for treatment of gout, was admitted to our hospital. Skin biopsies were taken and he was started on a
steroid infusion. Within hours of admission, he developed acute compartment syndrome of the dominant forearm
and hand.
Conclusions: Despite its rare incidence, toxic epidermal necrolysis is a condition with a high incidence of
complications and mortality. Patients with severe conditions affecting a large degree of the skin surface area
should be treated as promptly and effectively as patients with burns, with close monitoring and the anticipation
that rare musculoskeletal complications might arise. The association of compartment syndrome and toxic
epidermal necrolysis might lead to a rapid deterioration and fatal systemic involvement and multiple organ failures.
Introduction
Toxic epidermal necrolysis (TEN) lies within the spec-
trum of severe cutaneous adverse reactions (SCAR)
induced by drugs, and affects the skin and mucous
membranes [1,2]. TEN is considered a medical emer-
gency as it may be potentially fatal and carries a high
mortality rate. It is characterized by mucocutaneous ten-
derness and typically hemorrhagic erosions, erythema
and more or less severe epidermal detachment present-
ing as blisters and areas of denuded skin [3]. In 1995, a
case-control study assessed the medications that may be
related to TEN [4]. According to a more recent case-
control study, several drugs were confirmed to be at
‘high risk’ of inducing TEN, including: anti-infectives
such as cotrimoxazole and sulfonamides, allopurinol,
carbamazepine, phenytoin, phenobarbital and non-ster-
oidal anti-inflammatory drugs (NSAIDs) of the oxicam
type. Other drugs with ‘significant but lower risk’
included acetic acid NSAIDs, macrolides, quinolones,
cephalosporins and tetracyclines [5]. Among these
drugs, allopurinol is considered to be the most common
cause of TEN in Europe [6,7]. Many previous studies
have reported cases of allopurinol-induced TEN, and
some have noted that the outcome of allopurinol-
induced TEN is particularly lethal [8,9].
Case presentation
We report a rare case of compartment syndrome in the
forearm of a 62-year-old Caucasian man of northern
European origin who was recently diagnosed as having
gout and prescribed allopurinol at a therapeutic dose by
his general practitioner. Within less than 12 hours of
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drug administration our patient noticed oral mucosal
blistering and erosions, followed by the appearance of a
vesicular rash on his back. The lesions rapidly pro-
gressed within 24 to 36 hours to involve nearly his
entire body surface area affecting his face, neck, torso,
both arms, legs and perineum (more than 90% of his
body surface area was affected) with the development of
atypical and confluent flat target lesions with bullae in
their centers (Figure 1). The development of those
lesions was followed by extensive cutaneous sloughing
and was associated with conjunctivitis, high-grade fever
and malaise. According to the consensus definition pro-
posed by Bastuji-Garin et al. in 1993 [10], our patient
was diagnosed as having toxic epidermal necrolysis with
spots (detachment above 30% of the body surface area
plus widespread purpuric macules or flat atypical tar-
gets). He was also evaluated according to the severity of
illness score of toxic epidermal necrolysis (SCORTEN)
[11] and given a score of 5 (he was over 40 years of age,
with no malignancy, more than 10% of his body surface
area detached, he had tachycardia, elevated serum urea
and serum bicarbonate, and normal glucose levels). He
was admitted to the hospital under the care of a medical
team for investigation. Full blood count, blood glucose,
serum urea, creatinine, bicarbonate and electrolyte tests
and oral, rectal and skin biopsies were taken (Figure 2)
and a diagnosis of TEN with spots was made following
dermatological review with acute renal and hepatic func-
tion impairment. He was started on supportive
intravenous antibiotics, immunoglobulins (IGg), fluid
resuscitation and allopurinol administration was
stopped. The orthopedic team was asked to examine
him later that day following his experiencing excruciat-
ing pain in his left forearm and hand (dominant arm)
that was not responding to analgesia. On suspicion of
compartment syndrome, compartment pressures were
measured in both limbs on the ward. Compartment
pressures were found to be elevated in both anterior (75
mmHg) and posterior compartments and deep (65
mmHg) in the left forearm. He was taken to the operat-
ing room and immediate fasciotomies were carried out
with decompression of the median nerve in his carpal
tunnel. His symptoms improved post-operatively and
with the improvement in his renal and skin conditions
he was taken to the operating room within 48 hours for
wound inspection and successful secondary closure (Fig-
ure 3). He was admitted to the intensive care unit for
two weeks and then discharged to the general medical
ward for rehabilitation with a total duration of five
weeks of hospitalization. Following this, he had a full
recovery and was discharged with no residual musculos-
keletal damage.
Discussion
TEN syndrome is an uncommon, acute, life-threatening,
medication-induced disorder with a reported mortality
rate of up to 60% [8]. Different variables have been
identified as risk factors. Drug-induced TEN is the main
Figure 1 Macropapular and vesicular drug eruptions.
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documented cause of TEN. More than 100 different
drugs are considered as having caused TEN, but only a
minority of them accounts for the majority of cases.
These principal culprits are anti-infectives such as
cotrimoxazole and sulfonamides, allopurinol, carbamaze-
pine, phenytoin, phenobarbital, NSAIDs of the oxicam
type, acetic acid NSAIDs, macrolides, quinolones, cepha-
losporins and tetracyclines [5]. The management of such
Figure 2 A histopathological specimen (stained with hematoxylin and eosin) showing typical features of toxic epidermal necrolysis: acute
interface dermatitis, extensive full thickness keratinocyte necrosis and vascular degeneration of the dermoepidermal junction (×200).
Figure 3 Left forearm and wrist after fasciotomy and median nerve decompression.
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patients is primarily supportive, with particular attention
to body fluid balance, nutritional status, pain relief, early
treatment of eventual sepsis, and meticulous skin care
[3]. Recently, high-dose intravenous immunoglobulins
have been advocated to treat TEN in combination with
optimal care in a burn unit [9], as sepsis is a serious
complication in patients with TEN [3].
Acute compartment syndrome (ACS) is defined as the
development of increased pressure in a confined ana-
tomic space that compromises circulation and leads to
ischemia of the contained muscles and nerves. Several
theories have been proposed regarding the pathophysiol-
ogy of ACS. The arteriovenous gradient theory is argu-
ably the most popular. It states that increased tissue
pressure increases local venous pressure. This increased
venous pressure approaches the pressure in the supply-
ing arteries thus decreasing the arteriovenous pressure
gradient. Local blood flow decreases as the gradient
decreases and oxygen delivery to the surrounding tissue
drops below demand. Muscle ischemia results in myo-
cyte lysis and the release of toxic intracellular chemicals
into the extracellular space. Microvascular damage leads
to capillary leak, edema, and an increased compartment
pressure. Muscle ischemia eventually progresses to mus-
cle death. Over time the muscle is replaced with dense
fibrous tissue, which results in limb contracture.
Ischemic contracture, first described by Volkmann in
1881, is one known endpoint of untreated increased
pressure within a confined forearm compartment. This
pathologic event results in an atrophic and severely con-
tracted extremity with muscle and nerve fibrosis.
Immunopathological mechanisms of TEN include
recruitment of cluster of differentiation 4 (CD4)+ T
cells in the dermis and CD8+ T cells in the epidermis
thus inducing a T helper (TH)1 cell reaction [3].
Recruited memory CD4+ and cytotoxic CD8+ T cells
produce interferon g (IFNg) and tumor necrosis factor a
(TNFa), both triggering massive apoptosis of keratino-
cytes through one of two main mechanisms: the per-
forin/granzyme B mechanism and lytically active Fas
ligand (Fas-L) mechanism [12]. Moreover, the produc-
tion of TNFa would increase the expression of major
histocompatibility complex (MHC) class I antigens in
keratinocytes, making them more sensitive to cytotoxic
cells producing perforin and granzyme B [3]. Recently in
2008, Chung et al. demonstrated that the cytolytic pro-
tein granulysin is probably the most important factor in
epidermal apoptosis observed in TEN. Its concentration
in the blister fluid was several orders of magnitude
higher than that of other cytokines, such as perforin,
granzyme B or Fas-L and this concentration was found
to be positively correlated with disease severity [13].
Later, functionally active cells carrying the killer effector
receptor CD94/NKG2C were detected in the blister
fluid and the peripheral blood of patients with TEN and
the authors postulated that this receptor might be
involved in triggering cytotoxic T cells in the acute
stage of the disease [14]. Some studies have shown that
apart from acting as target cells in TEN, keratinocytes
may also be cytolytically active through their further
production of TNFa and Fas-L and hence trigger even
more massive apoptosis [3].
On occasion, for reasons that are not entirely clear, the
inflammatory response may spiral out of control, pro-
gressing until it involves the entire body. The circulatory
system loses its integrity followed by the breakdown of
the adherens junctions between the endothelial cells lin-
ing the capillaries, allowing fluid to leak into the tissue
spaces. Trauma from electrical injuries and burns, and
snakebite or envenomation injuries may cause a cascade
of events that lead to the rapid formation of edema. Simi-
larly, thermal and chemical burns may incite a cascade of
events involving substantial tissue injury and systemic
response with associated increases in vascular permeabil-
ity and interstitial edema. It is important to recognize
that compartment syndrome has been described in the
uninjured limb of up to 2% of patients with burns, occur-
ring as the result of a systemic inflammatory response
and the requirement for extensive fluid resuscitation.
We believe that in the case of our patient, the combi-
nation of capillary endothelial damage with subsequent
increase of capillary permeability and interstitial fluid
edema in addition to the inflammatory response affect-
ing the dermis associated with a certain degree of loss
of skin elasticity predisposed our patient to compart-
ment syndrome. Similar conditions have been noted in
patients with burns and have suggested early limb
escharotomies or fasciotomies in patients with full-
thickness burns with close monitoring of peripheral cir-
culation [15]. To the best of our knowledge there have
been no documented similar cases (investigated via
PubMed searches or any associated references in derma-
tology textbooks (Rooks)).
Conclusions
TEN, despite its rare incidence, is a condition with a
high incidence of complications and mortality. Patients
with severe conditions with a large degree of affected
surface area should be treated as promptly and effec-
tively as patients with burns, with close monitoring and
anticipation that rare musculoskeletal complications
might arise. The association of compartment syndrome
and TEN might lead to a rapid deterioration and fatal
systemic involvement and multiple organ failures.
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